<DOC>
	<DOCNO>NCT01122095</DOCNO>
	<brief_summary>Hypothesis 1 : Patients psoriasis clinical laboratory assessment differ control patient . Hypothesis 2 : Patients psoriasis laboratory alteration correlate clinical characteristic psoriasis .</brief_summary>
	<brief_title>Cross-sectional Evaluation Biological Markers Cardiovascular Disease Children Adolescents With Psoriasis</brief_title>
	<detailed_description>Psoriasis initially consider inflammatory condition primarily skin . However , advance medical knowledge allow insight wide-ranging systemic effect long-term uncontrolled inflammation , thus shift concept psoriasis inflammatory disease restrict skin systemic process . Adults w/ psoriasis high rate obesity , hypertension , diabetes , hyperlipidemia smoking prevalence risk factor increase extent psoriasis increases.1 It uncertain relate behavioral reaction psoriasis separate part disease process . Inflammation role pathogenesis cardiovascular disease note multiple observational study psoriasis patient demonstrate increase risk arterial venous event , notably myocardial infarction , cerebrovascular event , pulmonary embolus , cardiovascular death mortality overall . Specifically , Gelfand et . al . show increase relative risk myocardial infarction increase hazard ratio mortality patient severe psoriasis , notably , show high risk young adult patient . There paucity data risk psoriasis pediatric adolescent age group .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects race ethnicity meet follow criterion eligible enrollment study : 1 . The subject diagnosis typical psoriasis , without arthritis , base clinical evaluation investigator prior diagnosis pediatric dermatologist 2 . Persons reside US . 3 . Subjects 0 18 year age . 4 . Subjects/Guardians willing able comply requirement study . 5 . Subjects/Guardians willing able give inform consent . 6 . The subject general good health opinion investigator . 1 . Over 18 year age . 2 . Subject diagnosis congenital heart disease . 3 . Subject cardiac catheterization surgery . 4 . Subject take cardiac medication ( calcium channel blocker , beta blocker , vasotropic medicine ) within past 2 year . 5 . Subjects determine atypical psoriasis isolate palmoplantar psoriasis . 6 . Subject diagnosed systemic inflammatory disease include atopic dermatitis , severe acne vulgaris , inflammatory bowel disease , juvenile idiopathic arthritis , connective tissue disease similar condition . 7 . Having autoimmune immunodeficiency disease . 8 . Presence active systemic fungal , bacterial , viral infection . 9 . Presence active systemic malignancy . 10 . Mental illness history drug alcohol abuse , opinion investigator , would interfere participant 's ability comply study requirement . 11 . Inability unwillingness participant give write informed consent . Control 1 . Age 18 year . 2 . Ability willingness provide inform consent . Control 1 . Over 18 year age . 2 . Subject diagnosis congenital heart disease . 3 . Subject cardiac catheterization surgery . 4 . Subject take cardiac medication ( calcium channel blocker , beta blocker , vasotropic medicine ) within past 2 year . 5 . Subjects determine psoriasis type family history ( first degree relative ) psoriasis . 6 . Subject diagnosed systemic inflammatory disease include atopic dermatitis , severe acne vulgaris , inflammatory bowel disease , juvenile idiopathic arthritis , connective tissue disease similar condition . 7 . Having autoimmune immunodeficiency disease . 8 . Presence active systemic fungal , bacterial , viral infection . 9 . Presence active systemic malignancy . 10 . Mental illness history drug alcohol abuse , opinion investigator , would interfere participant 's ability comply study requirement . 11 . Inability unwillingness participant give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Cardiovascular risk</keyword>
</DOC>